OR WAIT 15 SECS
© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
January 25, 2021
Here’s a preview of the featured content to watch for this week on Drug Topics®.
January 22, 2021
Officials with the FDA have approved cabotegravir and rilpivirine, injectable formulation (Cabenuva; ViiV Healthcare) as a complete regimen for the treatment of HIV-1 infection in adults.
Here's the roundup of the latest coronavirus-related news.
Alliance will provide insight, education, and training opportunities to pharmaceutical and life sciences professionals.
January 21, 2021
A survey from APhA reported that the majority of pharmacists plan to or have received a COVID-19 vaccine.
In its next live webinar event, MJH Life Sciences™ COVID-19 Coalition will explore emerging mutations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
January 20, 2021
In a letter to President Joe Biden, ASHP and more than 50 signers called for use of federal resources and expansion of the vaccinator workforce to confront the slow ramping up of COVID-19 vaccinations.
Apart from COVID-19, there are several other industry trends taking root that will likely have a transformative effect on the profession in years to come.
January 19, 2021
Users of the PrimeRx pharmacy management technology system now have direct integration access to Surescripts Real-Time Prescription Benefit.
January 18, 2021
ISMP identified the most commonly reported errors and hazards associated with the new COVID-19 vaccines.
“We have met the enemy, and they are ours!”
January 15, 2021
President-elect Joe Biden revealed his COVID-19 plan, which includes a disciplined focus on vaccination efforts.
Here's the latest coronavirus-related news.
January 14, 2021
On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for coronavirus disease 2019 (COVID-19).
January 12, 2021
In a final briefing, OWS recommended states expand vaccination to all individuals 65 and older or those with comorbidities.
January 11, 2021
January 08, 2021
The FDA has identified 3 molecular tests that may be impacted by an emerging SARS-CoV-2 variant.
January 07, 2021
AmerisourceBergen has announced its acquisition of the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses.
January 05, 2021
In a statement, FDA officials recommended that all health care professionals continue to adhere to the FDA-authorized dosing and schedules of the COVID-19 vaccines.